Vagus nerve stimulation in refractory epilepsy: Effects on pro-and anti-inflammatory cytokines in peripheral blood

NeuroImmunoModulation

Volumn 18, Issue 1, 2010, Pages 52-56

  Majoie, H J M ^a,b   Rijkers, K ^c   Berfelo, M W ^c   Hulsman, J A R J ^a   Myint, A ^d   Schwarz, M ^d   Vles, J S H ^b  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b Department of Neurology ^*  (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anticholinergic reflex; Inflammation; Kynurenin; Neurostimulation; Serotonin; Tryptophan

Indexed keywords

3 HYDROXYKYNURENINE; 5 HYDROXYINDOLEACETIC ACID; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINE; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; IMMUNE SYSTEM; MALE; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFRACTORY PERIOD; TRYPTOPHAN METABOLISM; VAGUS NERVE STIMULATION;

ADOLESCENT; ADULT; BRAIN; CHILD; CYTOKINES; EPILEPSY; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION; TRYPTOPHAN; UP-REGULATION; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 77954548499     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315530     Document Type: Article

References (25)

1. Salgado-Commissariat D, Alkadhi KA: Se-rotonin inhibits epileptiform discharge by activation of 5-HT 1A receptors in CA1 pyra-midal neurons. Neuropharmacology 1997; 36:1705-1712.
2. Shouse MN, Staba RJ, Saquib SF, Farber PR: Long-lasting effects of feline amygdala kin-dling on monoamines, seizures and sleep. Brain Res 2001; 892:147-165.
3. Hulkkonen J, Koskikallio E, Rainesalo S, Keranen T, Hurme M, Peltola J: The balance of inhibitory and excitatory cytokines is dif-ferently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Res 2004; 59: 199-205.
4. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T, Perego C, De Si-moni MG: Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002; 43(suppl 5):30-35.
5. Chugani DC, Chugani HT: Does serotonin have trophic effects in temporal lobe epilep-sy? Neurology 2003; 60:736-737.
6. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, et al: Quinolinic acid and kynurenine pathway metabolism in in-flammatory and non-inflammatory neuro-logical disease. Brain 1992; 115: 1249-1273.
7. Heyes MP, Wyler AR, Devinsky O, Yergey JA, Markey SP, Nadi NS: Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia 1990; 31:172-177.
8. Gallowitsch-Puerta M, Tracey KJ: Immuno-logic role of the cholinergic anti-inflamma-tory pathway and the nicotinic acetylcholine alpha 7 receptor. Ann NY Acad Sci 2005; 1062:209-219.
9. Myint AM, Kim YK: Cytokine-serotonin in-teraction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003; 61: 519-525.
10. Ben Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J, Treig T, Stefan H, Ramsay RE, Wernicke JF, et al: effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of pa-tients with partial seizures. Epilepsy Res 1995; 20:221-227.
11. Hammond EJ, Uthman BM, Wilder BJ, Ben Menachem E, Hamberger A, Hedner T, Ek-man R: Neurochemical effects of vagus nerve stimulation in humans. Brain research 1992; 583: 300-303.
12. Cramer JA, Ben Menachem E, French J: Re-view of treatment options for refractory epi-lepsy: new medications and vagal nerve stimulation. Epilepsy Res 2001; 47:17-25.
13. Majoie HJ, Berfelo MW, Aldenkamp AP, Re-nier WO, Kessels AG: Vagus nerve stimula-tion in patients with catastrophic childhood epilepsy, a 2-year follow-up study. Seizure 2005; 14:10-18.
14. Vezzani A, Balosso S, Ravizza T: The role of cytokines in the pathophysiology of epilepsy Brain Behav Immun 2008; 22: 797-803.
15. Liimatainen S, Fallah M, Kharazmi E, Pel-tola M, Peltola J: Interleukin-6 levels are in-creased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J Neurol 2009; 256: 796-802.
16. Hosoi T, Okuma Y, Nomura Y: The mecha-nisms of immune-to-brain communication in inflammation as a drug target. Curr Drug Targets Inflamm Allergy 2002; 1:257-262.
17. Pavlov VA, Tracey KJ: The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005; 19: 493-499.
18. Tracey KJ: The inflammatory reflex. Nature 2002; 420: 853-859.
19. De Herdt V, Bogaert S, Bracke KR, Raedt R De Vos M, Vonck K, Boon P: Effects of vagus nerve stimulation on pro-and anti-inflam-matory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009; 214:104-108.
20. Corcoran C, Connor TJ, O'Keane V, Garland MR: The effects of vagus nerve stimulation on pro-and anti-inflammatory cytokines in humans: a preliminary report. NeuroImmunomodulation 2005; 12: 307-309.
21. Yamamoto H, Shindo I, Egawa B, Horiguchi K: Kynurenic acid is decreased in cerebrospi-nal fluid of patients with infantile spasms. Pediatr Neurol 1994; 10: 9-12.
22. Yamamoto H: Studies on CSF tryptophan metabolism in infantile spasms. Pediatr Neurol 1991; 7:411-414.
23. Giroud M, Dumas R, Dauvergne M, DAthis P, Rochette L, Beley A, Bralet J: 5-Hydroxy-indoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions. Epilepsia 1990; 31:178-181.
24. Jameison K, Dinan TG: Glucocorticoids and cognitive function: from physiology to pathophysiology. Hum Psychopharmacol 2001; 16: 293-302.
25. Galimberti CA, Magri F, Copello F, Arbasi-no C, Cravello L, Casu M, Patrone V, Muri-aldo G: Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving an-tiepileptic drug treatment. Epilepsia 2005; 46:517-523.